Trial Profile
A Single-Center, Pharmacoepidemiology, Inception Cohort Study Comparing Effectiveness of Allopurinol, Febuxostat and Benzbromarone on Renal Function in Chronic Kidney Disease Patients with Hyperuricemia
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 01 Dec 2017
Price :
$35
*
At a glance
- Drugs Benzbromarone (Primary) ; Febuxostat (Primary) ; Allopurinol
- Indications Hyperuricaemia; Renal failure
- Focus Therapeutic Use
- 01 Dec 2017 New trial record
- 17 Nov 2017 Results published in the Nephrology Dialysis Transplantation Journal.